Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025)

Palomino Laboratories' Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $8.1 million for Q3 2025.

• In Q3 2025, Cash from Financing Activities rose 40476.29% year-over-year to $8.1 million; the TTM figure through Sep 2025 stood at $8.3 million (changed N/A YoY), while the FY2024 annual figure was $195437.0, up 146.58% from the prior year.
• Cash from Financing Activities came in at $8.1 million for Q3 2025 at Palomino Laboratories, up from $19980.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $8.1 million in Q3 2025 to a low of $20.0 in Q1 2025.
• A 3-year average of $1.4 million and a median of $38404.5 in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 155.0% in 2024 and jumped 40476.29% in 2025, its largest moves.
• Palomino Laboratories' Cash from Financing Activities stood at $56766.0 in 2023, then jumped by 155.0% to $144753.0 in 2024, then soared by 5518.33% to $8.1 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $8.1 million, $19980.0, and $20.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison